FDA Inspection 1336054 — LEASEIR TECHNOLOGIES SLU
The FDA completed an inspection of LEASEIR TECHNOLOGIES SLU on Sep 2, 2026 in Gijon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 2, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Gijon (Spain)
Citations
| ID | CFR | Description |
|---|---|---|
| 23024 | ISO 13485:2016 Clause 4.1.5 | Inadequate monitoring and control over outsourced processes |
| 23127 | ISO 13485:2016 Clause 7.3.8 | Design and development transfer procedures not documented |
| 23145 | ISO 13485:2016 Clause 7.4.1 | Records of supplier (re)evaluation, selection, and monitoring not maintained |
| 23164 | ISO 13485:2016 Clause 7.5.4 | Records of servicing activities not maintained |
| 23215 | ISO 13485:2016 Clause 8.2.2 | Complaint handling procedures lack required elements |
| 23251 | ISO 13485:2016 Clause 8.4 | Data analysis did not include data from monitoring, measurement, other sources |
| 23258 | ISO 13485:2016 Clause 8.5.2 | Corrective action procedures not documented |
| 23260 | ISO 13485:2016 Clause 8.5.3 | Preventive action not determined |